Related Experiment Videos
MethyLight: a high-throughput assay to measure DNA methylation
C A Eads1, K D Danenberg, K Kawakami
1Department of Surgery, University of Southern California School of Medicine, Norris Comprehensive Cancer Center, Los Angeles 90033, USA.
Nucleic Acids Research
|March 29, 2000
Summary
This study introduces MethyLight, a rapid, high-throughput assay for DNA methylation analysis. This quantitative PCR method accurately detects methylation patterns in tumor samples, aiding cancer research.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Genomics
Background:
- Cytosine-5 DNA methylation at CpG sites is crucial in vertebrates.
- Aberrant CpG island methylation silences tumor-suppressor genes in human cancers.
- Existing methylation analysis methods are often manual and low-throughput.
Purpose of the Study:
- To develop a high-throughput, quantitative assay for DNA methylation analysis.
- To enable rapid and accurate epigenetic profiling of clinical specimens.
- To overcome limitations of current manual methylation detection techniques.
Main Methods:
- Utilized fluorescence-based real-time PCR (TaqMan) technology.
- Developed a novel assay named MethyLight.
- No post-PCR manipulations were required.
Main Results:
- MethyLight is highly sensitive, detecting methylated alleles amid a 10,000-fold excess of unmethylated ones.
- The assay is highly quantitative, accurately determining relative DNA methylation prevalence.
- Successfully distinguished mono-allelic and bi-allelic methylation of the MLH1 gene in colorectal tumors.
Conclusions:
- MethyLight offers a significant advancement for high-throughput DNA methylation analysis.
- This technique enhances the ability to rapidly generate epigenetic profiles from tumor samples.
- Facilitates molecular insights from clinical specimens for cancer research.